MIST vs SPG · rev $797.0K vs rev $3.55B
Milestone Pharmaceuticals Inc (MIST) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported MIST revenue for 2026-06-30 was $797.0K. Net income was -$54.7M. MIST currently screens at market cap $160.6M.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
MIST currently screens at market cap $160.6M. SPG currently screens at market cap $0.
Not investment advice. Open the MIST and SPG stock pages for the full models.
Not investment advice.